---
title: "Ambey Laboratories Ltd (DHANSA) — Share Price, Financials & Analysis"
symbol: "AMBEY"
company: "Ambey Laboratories Ltd"
canonical: "https://tapetide.com/stocks/AMBEY"
isin: "INE0M3I01029"
nse_symbol: "DHANSA"
sector: "Chemicals"
industry: "Pesticides & Agrochemicals"
market_cap_cr: 70.22
generated_at: "2026-10-15T10:22:52.296Z"
---

# Ambey Laboratories Ltd (DHANSA)

Canonical page: https://tapetide.com/stocks/AMBEY

## Company

- **NSE Symbol:** DHANSA
- **ISIN:** INE0M3I01029
- **Sector:** Chemicals
- **Industry:** Pesticides & Agrochemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2024-07-11
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** ambeylab.com

## About

Incorporated in 1985, Ambey Laboratories Ltd is in the business of manufacturing and distribution of agro and home hygiene products.[1]

## Latest Price

- **Price:** ₹26.1
- **Change:** 0 (0%)
- **Open:** ₹26.1
- **Day High:** ₹26.1
- **Day Low:** ₹26.1
- **Previous Close:** ₹26.1
- **Volume:** 2000
- **As Of:** 2026-10-15T04:13:14+00:00

## Key Fundamentals

Price-based figures as of 2026-10-15T09:43:14+05:30.

Observed at 2026-10-15T04:43:09.873910Z.

- **Market Cap:** ₹70.22 Cr
- **Classification:** SME
- **P/E (TTM):** 18.64
- **EPS (TTM):** ₹1.4
- **Book Value:** ₹29.87
- **Price to Book:** 0.87
- **Dividend Yield:** 0%
- **ROE:** 5.59%
- **ROCE:** 8.48%
- **Debt to Equity:** 0.54
- **Revenue (yearly):** ₹142.8 Cr
- **Net Income:** ₹5.5 Cr
- **EBITDA:** ₹12.2 Cr
- **52-Week High:** ₹47
- **52-Week Low:** ₹16.2
- **RSI (14):** 44.4

## Tapetide Score

- **Score:** 39 / 100
- **Score date:** 2026-10-14
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Flat
- **Percentile:** 11.9 (of 4490 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 49.88 | 9% |
| growth | 39.23 | 9% |
| momentum | 55.11 | 12% |
| ownership | 44.89 | 24% |
| quality | 29.61 | 22% |
| valuation | 40.56 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.68 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 60.5 to 112 days.
- Working capital days have increased from 64.4 days to 126 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -368.1% | -178.04% | -151.29% |
| ebitda margin growth | -18.18% | — | — | — |
| net income growth | -65% | -10% | 10% | — |
| revenue growth | -26.09% | 3% | 16% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
| --- | --- | --- | --- | --- |
| Sales | 60 | 68 | 64 | 68 |
| Expenses | 56 | 62 | 60 | 62 |
| Operating Profit | 4 | 6 | 4 | 6 |
| OPM % | 7 | 9 | 6 | 9 |
| Other Income | 1 | 1 | 1 | 0 |
| Interest | 1 | 2 | 1 | 1 |
| Depreciation | 1 | 1 | 2 | 2 |
| Profit before tax | 3 | 4 | 2 | 3 |
| Tax % | 33 | 18 | 25 | 13 |
| Net Profit | 2 | 3 | 2 | 3 |
| EPS in Rs | 0.94 | 1.19 | 0.73 | 1.05 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 82 | 85 | 105 | 120 | 131 | 132 |
| Expenses | 72 | 74 | 97 | 111 | 122 | 122 |
| Operating Profit | 10 | 10 | 8 | 9 | 10 | 10 |
| OPM % | 12 | 12 | 7 | 8 | 7 | 7 |
| Other Income | 1 | 1 | 3 | 1 | 2 | 1 |
| Interest | 4 | 3 | 2 | 2 | 3 | 2 |
| Depreciation | 3 | 3 | 3 | 2 | 3 | 4 |
| Profit before tax | 3 | 5 | 6 | 6 | 6 | 5 |
| Tax % | -235 | 26 | 5 | -40 | 21 | — |
| Net Profit | 10 | 4 | 5 | 8 | 5 | 4 |
| EPS in Rs | 211.28 | 20.11 | 29.52 | 4.13 | 1.92 | 1.78 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 5 | 18 | 18 | 19 | 25 | 25 |
| Reserves | -13 | 1 | 1 | 13 | 51 | 67 |
| Borrowings | 33 | 18 | 14 | 30 | 41 | 40 |
| Other Liabilities | 20 | 19 | 21 | 18 | 10 | 9 |
| Total Liabilities | 45 | 56 | 54 | 79 | 127 | 140 |
| Fixed Assets | 16 | 25 | 25 | 24 | 23 | 22 |
| CWIP | 1 | 0 | 0 | 4 | 16 | 17 |
| Investments | 0 | 0 | 1 | 1 | 0 | 0 |
| Other Assets | 28 | 31 | 28 | 51 | 88 | 101 |
| Total Assets | 45 | 56 | 54 | 79 | 127 | 140 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 3 | 6 | 10 | -13 | -34 |
| Cash from Investing Activity | -1 | -1 | -4 | -5 | -14 |
| Cash from Financing Activity | -1 | -5 | -6 | 18 | 48 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 2 | 5 | 7 | -18 | -48 |
| CFO/OP | 23 | 47 | 120 | -131 | -347 |

### Ratios

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 31 | 37 | 12 | 57 | 112 |
| Inventory Days | — | — | 78 | 75 | 99 |
| Days Payable | — | — | 74 | 54 | 22 |
| Cash Conversion Cycle | 31 | 37 | 17 | 78 | 189 |
| Working Capital Days | -10 | 11 | 18 | 49 | 126 |
| ROCE % | — | 25 | 22 | 18 | 10 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- |
| Promoters | 69.9% | 70.11% | 70.15% | 70.15% | 65.05% |
| FIIs | 1.46% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0.72% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 20.28% | 22.4% | 22.36% | 22.81% | 26.58% |
| Others | 8.36% | 7.5% | 7.49% | 6.32% | 8.37% |
| No. of Shareholders | 1520 | 1327 | 1291 | 1224 | 1201 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 4 / 5 / 10

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 26.97 | Sell |
| EMA (10) | 27.5 | Sell |
| SMA (20) | 29.34 | Sell |
| EMA (20) | 27.74 | Sell |
| SMA (50) | 25.35 | Buy |
| EMA (50) | 26.56 | Sell |
| SMA (100) | 25.36 | Buy |
| EMA (100) | 26.29 | Sell |
| SMA (200) | 28.49 | Sell |
| EMA (200) | 28.81 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 44.4 | Neutral |
| MACD (12,26,9) | 0.07 | Sell |
| Stochastic (14,3,3) | 36.82 | Neutral |
| ADX (14) | 20.44 | Neutral |
| Williams %R (14) | -82.11 | Buy |
| ATR (14) | 1.32 | High Volatility |
| ROC (12) | -11.82 | Sell |
| Stoch RSI (14) | 15.58 | Buy |
| UO (7,14,28) | 45.72 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 2026-06-11 | [Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/AMBEY_11062026161418_Intimation_Transcript_of_earnings_call_signed.pdf) |
| 2026-06-06 | [Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/AMBEY_06062026182336_IntimationEarningscall.pdf) |
| 2026-06-05 | [Investor Presentation](https://nsearchives.nseindia.com/corporate/AMBEY_05062026165638_Investor_Presentation.pdf) |
| 2026-06-02 | [Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/AMBEY_02062026175559_Prior_Intimation_Earnings_Call.pdf) |
| 2026-05-31 | [Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/AMBEY_31052026155038_Intimation_for_Newspaper_advt_31052026_signed.pdf) |
| 2026-05-30 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/AMBEY_30052026000624_Outcome_of_BM.pdf) |
| 2026-05-29 | [Structural Digital Database](https://nsearchives.nseindia.com/corporate/AMBEY_29052026135036_SDD_Compliance_Certificate.pdf) |
| 2026-05-26 | [Disclosure under SEBI Takeover Regulations](https://nsearchives.nseindia.com/corporate/team_sandeshc_05052026132302_28.pdf) |
| 2026-05-26 | [Committee Meeting Updates](https://nsearchives.nseindia.com/corporate/AMBEY_26052026130714_Outcome_of_committee_meeting.pdf) |
| 2026-05-26 | [Name Change](https://nsearchives.nseindia.com/corporate/AMBEY_26052026160422_Intimation_for_Name_Change.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| 2025 | [Financial Year 2025](https://archives.nseindia.com/annual_reports/SME_AR_28467_AMBEY_2024_2025_A_4740905_04092025190011.pdf) |
| 2024 | [Financial Year 2024](https://archives.nseindia.com/annual_reports/SME_AR_26178_AMBEY_2023_2024_07092024195044.pdf) |
| 2020 | [Financial Year 2020](https://www.bseindia.com/bseplus/AnnualReport/517224/68188517224.pdf) |
| Mar 2019 | [Financial Year 2019](https://www.bseindia.com/bseplus/AnnualReport/517224/5172240319.pdf) |
| Mar 2018 | [Financial Year 2018](https://www.bseindia.com/bseplus/AnnualReport/517224/5172240318.pdf) |
| Mar 2017 | [Financial Year 2017](https://www.bseindia.com/bseplus/AnnualReport/517224/5172240317.pdf) |
| Mar 2016 | [Financial Year 2016](https://www.bseindia.com/bseplus/AnnualReport/517224/5172240316.pdf) |
| Mar 2015 | [Financial Year 2015](https://www.bseindia.com/bseplus/AnnualReport/517224/5172240315.pdf) |
| Mar 2014 | [Financial Year 2014](https://www.bseindia.com/bseplus/AnnualReport/517224/5172240314.pdf) |
| Mar 2013 | [Financial Year 2013](https://www.bseindia.com/bseplus/AnnualReport/517224/5172240313.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Jun 2026 | Concall - Jun 2026 |

### Credit Rating Reports

| Date | Document |
| --- | --- |
| 2025-10-28 | Credit rating update — Brickwork Ratings |
| 2021-02-05 | Credit rating update — CARE Ratings |
| 2021-02-05 | Credit rating update — CARE Ratings |
| 2021-01-11 | Credit rating update — CARE Ratings |
| 2020-08-11 | Credit rating update — CARE Ratings |
| 2019-11-14 | Credit rating update — CARE Ratings |
| 2019-07-05 | Credit rating update — CARE Ratings |
| 2018-03-05 | Credit rating update — CARE Ratings |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-15T10:22:52.296Z.